LQLinyu Qiu

Linyu Qiu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Linyu Qiu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Chunyan Yang

    School of Pharmacy, Institute of Material Medica, North Sichuan Medical College, Nanchong 637100, China

    1 shared publication
  • Jinmin Wang

    School of Pharmacy, Institute of Material Medica, North Sichuan Medical College, Nanchong 637100, China

    1 shared publication
  • Jun-Li Yang

    CAS Key Laboratory of Chemistry of Northwestern Plant Resources, Key Laboratory for Natural Medicine of Gansu Province, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (CAS), Lanzhou, 730000, PR China

    1 shared publication
  • Kongming Fan

    School of Pharmacy, Institute of Material Medica, North Sichuan Medical College, Nanchong 637100, China

    1 shared publication
  • Li Ran

    School of Pharmacy, Institute of Material Medica, North Sichuan Medical College, Nanchong 637100, China

    1 shared publication
  • Qiaofeng Fu

    School of Pharmacy, Institute of Material Medica, North Sichuan Medical College, Nanchong 637100, China

    1 shared publication

Latest Publications

  • Open Access

    Bio-Assay-Guided Isolation of Fractions and Constituents with Antioxidant and Lipid-lowering Activity from Allium cepa

    by Kongming Fan, Yan Li, Qiaofeng Fu, Jinmin Wang, Yong Lin, Linyu Qiu, Li Ran, Junli Yang, Chunyan Yang

    Active fractions and constituents with antioxidant and lipid-lowering activities were investigated using bio-assay-guided isolation and identification. The data showed that the antioxidant fraction of A. cepa was AC50%, the main constituents of which were quercetin and isoquercitrin, by way of both ultra-high performance liquid chromatography–mass spectrometry (UPLC-MS) and bio-assay-guided purification and elucidation. Similarly, the lipid-lowering active fraction of A. cepa was AC30% with the main constituents of 3,4-dihydroxybenzoic acid and quercetin 3,4′-O-diglucoside. Also, bio-assay-guided isolation led to the isolation and identification of five known compounds with a purity of more than 98%, and quercetin was both the best free radical scavenger and lipid-lowering constituent. Moreover, the mechanism of the lipid-lowering effect of AC30% might be its reduction in mRNA expression levels of sterol regulatory element binding protein 2 (SREBP2) and FAS gene in lipid synthesis. Otherwise, reducing the mRNA expression level of lipid synthesis genes, including SREBP1, SREBP2, fatty acid synthetase (FASN), β-Hydroxy β-methylglutaryl-CoA (HMGCR), stearoyl CoA desaturase 1 (SCD1), and increasing the mRNA expression level of lipid decomposition gene, such as carnitine palmitoyl transferease-1 (CPT1), might be involved in the lipid-lowering activity of quercetin. This study suggested that Allium cepa might be used to prevent and treat oxidative stress and dislipidemia-related disorders, including NAFLD.